Bone drug suppresses wandering tumor cells in breast cancer patients; May reduce metastatic disease

The bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery, new research suggests. When the drug was given along with chemotherapy for three months before breast cancer surgery, it reduced the number of women who had tumor cells in their bone marrow at the time of surgery.

Read the whole article on Science Daily

More from Science Daily